Evaluation of EED Inhibitors as a Class of PRC2-Targeted Small Molecules for HIV Latency Reversal-Reference-Cited by-同舟云学术

Evaluation of EED Inhibitors as a Class of PRC2-Targeted Small Molecules for HIV Latency Reversal

Published:2020-04-29 Issue:7 Volume:6 Page:1719-1733
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Turner Anne-Marie W.¹²,Dronamraju Raghuvar³,Potjewyd Frances⁴,James Katherine S.¹,Winecoff Daniel K.¹,Kirchherr Jennifer L.¹,Archin Nancie M.¹²,Browne Edward P.¹²,Strahl Brian D.³^ORCID,Margolis David M.¹²⁵⁶,James Lindsey I.¹⁴^ORCID

Affiliation:

1. UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599, United States

2. Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599, United States

3. Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599, United States

4. Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

5. Department of Epidemiology, University of North Carolina at Chapel Hill School of Public Health, Chapel Hill, North Carolina 27599, United States

6. Department of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599, United States

Funder

National Institute of Neurological Disorders and Stroke

National Institute of Allergy and Infectious Diseases

National Institute on Drug Abuse

National Institute of Mental Health

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

http://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.9b00514

Reference51 articles.